Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > control of the trading float

<< Previous

Bullboard Posts

Next >>

Post by Chefboy69on May 18, 2023 11:56am

148 Views

Post# 35454668

control of the trading float

see what they can do??

so, a bunch of traders pile into a stock( buying up VERY LARGE POSITIONS)

then they buy and sell and SHORT

creating trading opportunites...making a stock essentially a trading vehicle

AND RINSE AND REPEAT it over and over

its the SOP right now in the market for all stocks!!

<< Previous

Bullboard Posts

Next >>

TELUS adds 347K customers in Q3